3/25
12:41 pm
stro
Rating for STRO
Low
Report
Rating for STRO
3/25
12:41 pm
stro
Rating for STRO
Low
Report
Rating for STRO
3/24
08:30 am
stro
Sutro Biopharma (STRO) was upgraded by Wells Fargo & Company from "equal weight" to "overweight". They now have a $27.00 price target on the stock, up from $8.00.
Low
Report
Sutro Biopharma (STRO) was upgraded by Wells Fargo & Company from "equal weight" to "overweight". They now have a $27.00 price target on the stock, up from $8.00.
3/24
08:21 am
stro
Rating for STRO
Low
Report
Rating for STRO
3/24
08:21 am
stro
Rating for STRO
Low
Report
Rating for STRO
3/24
08:03 am
stro
Sutro Biopharma (STRO) was upgraded by HC Wainwright from "neutral" to "buy". They now have a $28.00 price target on the stock, up from $10.00.
Low
Report
Sutro Biopharma (STRO) was upgraded by HC Wainwright from "neutral" to "buy". They now have a $28.00 price target on the stock, up from $10.00.
3/24
06:11 am
stro
Sutro Biopharma upgraded to Buy from Neutral at H.C. Wainwright
High
Report
Sutro Biopharma upgraded to Buy from Neutral at H.C. Wainwright
3/24
06:11 am
stro
Sutro Biopharma upgraded to Buy from Neutral at H.C. Wainwright
High
Report
Sutro Biopharma upgraded to Buy from Neutral at H.C. Wainwright
3/23
09:28 pm
stro
Sutro Biopharma upgraded to Overweight from Equal Weight at Wells Fargo
High
Report
Sutro Biopharma upgraded to Overweight from Equal Weight at Wells Fargo
3/23
09:28 pm
stro
Sutro Biopharma upgraded to Overweight from Equal Weight at Wells Fargo
High
Report
Sutro Biopharma upgraded to Overweight from Equal Weight at Wells Fargo
1/20
06:01 am
stro
Sutro Biopharma (NASDAQ:STRO) was upgraded by analysts at Citigroup Inc. to an "outperform" rating.
Medium
Report
Sutro Biopharma (NASDAQ:STRO) was upgraded by analysts at Citigroup Inc. to an "outperform" rating.